Effects of Surgery Types in Patients With Pulmonary Nodules

Status Completed

Clinical Trial Summary

The investigators aimed to compare the pre-post operative effects of video-assisted thoracoscopy surgery (VATS) and thoracotomy on pulmonary function, exercise capacity, physical activity level, respiratory and peripheral muscle strength, inspiratory muscle endurance, quality of life, fatigue, dyspnea perception and pain in patients with pulmonary nodules.

Clinical Trial Description

According to global cancer statistics, lung cancer accounts for 11.6% of all cancer cases and it is the most common type of cancer in the world. Surgery is the primary treatment approach, especially in early stages lung cancer. Cardiopulmonary fitness of patients with lung cancer is lower than healthy individuals due to the disease itself and treatments. Pulmonary function, exercise capacity and physical activity level are affected in lung cancer depending on the resected lung tissue and the type of surgery. VATS and thoracotomy surgeries, which are the most preferred techniques in lung cancer, have advantages and disadvantages over each other. There are few studies compared the early effects of two surgeries on the pulmonary function, exercise capacity, physical activity, quality of life and fatigue. And also, no study compared the effects of two surgeries on respiratory muscle endurance and peripheral muscle strength, previously. According to sample size calculation, at least 15 patients with pulmonary lesion both VATS and thoracotomy groups would be included in the study. The demographic, physical and physiological characteristics were recorded from the patient files. Pulmonary function, functional exercise capacity, physical activity level, respiratory and peripheral muscle strength, inspiratory muscle endurance, quality of life, fatigue, dyspnea perception and pain were evaluated pre and two weeks after postoperative term. Primary outcomes were pulmonary function, functional exercise capacity and physical activity level. Secondary outcomes were respiratory and peripheral muscle strength, inspiratory muscle endurance, quality of life, fatigue, dyspnea perception and pain. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04805723
Study type	Interventional
Source	Gazi University
Contact
Status	Completed
Phase	N/A
Start date	July 10, 2018
Completion date	January 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05160571` - A Retrospective Multicenter Review to Evaluate the Performance of the Ion Endoluminal System in Sampling Pulmonary Lesions
Not yet recruiting	`NCT04156360` - Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer
Not yet recruiting	`NCT05848635` - Hydromorphone for Perioperative Analgesia in Lung Tumor Ablation Parallel Controlled	Phase 4
Recruiting	`NCT06074133` - A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules
Active, not recruiting	`NCT03893539` - Clinical Utility for Ion Endoluminal System	N/A
Recruiting	`NCT06335563` - Augmented Reality Navigation Versus Traditional CT Guidance for Preoperative Localization of Pulmonary Nodules	N/A
Recruiting	`NCT04890301` - Puncture Template Assisted Biopsy for Pulmonary Nodules	N/A
Completed	`NCT03731156` - Granulomatous Pneumocystis Pneumonia
Completed	`NCT00917137` - Transbronchial Needle Aspiration in the Diagnosis of Peripheral Pulmonary Malignancy	N/A
Recruiting	`NCT03824535` - 18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules	Phase 2
Completed	`NCT04182815` - Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors of the Lung
Completed	`NCT00906503` - Fludeoxyglucose F 18-PET/CT Scans in Patients Receiving Ultra Short-Term Dexamethasone For Lung Nodules	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.